RE:WHYhopeforthebest, "WHY HAS RONNIE BEEN UNABLE TO ATTRACK OUTSIDE INTEREST IN CEOPRO? WHY?"
The better observation: Isn't it f'n amazing how little CZO is on the verge of potentially disrupting large markets dominated by global giants? Visionary Gilles Gagnon has managed to develop PGX within the cashflow of the base business to within about seven months of commercial production and the decision point for mass industrialization with industry leader Natex. Being able to do this within cashflow Gilles hasn't needed to entertain the financial circus. He's been able to focus on advancing the business to today where it is stronger than ever and still 100% owned by CZO. No other company in the world has been able to achieve what Gilles has in this world of giants.
"Mr. Regnier added, “This is an exciting time in the Company’s history with the potential to generate growing value in the near and long term. I look forward to completing the development of technologies such as PGX, that continue to demonstrate its ability to successfully generate novel bioactive delivery systems at a quality that no other known technologies have been able to generate."
Gilles has even attracted Canadian pharma icon Ronnie Miller from the largest biotech company in the world who is 'thrilled'.
As PGX scale-up is completed, a licensing deal is signed, and product is available to the market even the morons will be able to understand. Then even BNN will finally catch on and make it a top pick.
Because of the competitive nature of business Gilles has also played his cards close to his chest. No preclinical data has ever been released for the avenanthramide pill. They have even worked to combine CZO's avenanthramide with PGX carriers with promising results but it's a secret. You don't want a giant to steal the prize.